The data and potential of LUM-201 (ibutamoren)

[madman]

Andrew Dauber, M.D., Chief of Endocrinology, Children's National Medical Center, Washington, D.C. discusses the data and potential of LUM-201 for children living with moderate pediatric growth hormone deficiency

 

[madman]

LUM-201 (ibutamoren) - The OraGrowtH212 trial

The OraGrowtH212 trial is a global study involving 80 patients in four arms, testing three different doses of a new drug compared to the standard dose of growth hormone. The study aims to measure catchup growth over an extended period, with promising interim results indicating comparable growth...

www.excelmale.com